REFERENCES
- Elbaz A., Amarenco P. Genetic Susceptibility and Ischaemic Stroke. Curr. Opin. Neurol. 1999; 12(1)47–55
- Hassan A., Markus H. S. Genetics and Ischaemic stroke. Brain. 2000; 123 (Pt 9):1: 784–812
- Kessler C., Spitzer C., Stauske D., Mende S., Stadmuller J., Walther R. The Apolipoprotein E and Beta-Fibrinogen G/A-455 Gene Polymorphisms are Associated with Ischemic Stroke Involving Large Vessel Disease. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 2880–2884
- Heywood D. M., Carter A. M., Catto A. J., Bamford J. M., Grant P. J. Polymorphisms of the Factor VII Gene and Circulating FVII:C Levels in Relation to Acute Cerebrovascular Disease and Poststroke Mortality. Stroke 1997; 28(4)816–821
- Catto A. J., Carter A. M., Stickland M., Bamford J. M., Davies J. A., Grant P. J. Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Promoter Polymorphism and Levels in Subjects with Cerebrovascular Disease. Thromb. Haemost. 1997; 77(4)730–734
- Longstreth W. T., Jr., Rosendaal F. R., Siscovick D. S., Vos H. L., Schwartz S. M., Psaty B. M., Raghunathan T. E., Koepsell T. D., Reitsma P. H. Risk of Stroke in Young Women and Two Prothrombotic Mutations, Factor V Leiden and Prothrombin Gene Variant (G20210A). Stroke. 1998; 29(3)577–580
- Corral J., Gonzalez-Conejero R., Lozano M. L., Rivera J., Vicente V. Genetic Polymorphisms of Factor VII are not Associated with Arterial Thrombosis. Blood Coagul. Fibrinolysis. 1998; 9(3)267–272
- Catto A. J., Kohler H. P., Bannan S., Stickland M., Carter A., Grant P. J. Factor XIII Val 34 Leu, a Novel Association with Primary Intracerebral Hemorrhage. Stroke. 1998; 29(4)813–816
- Carter A. M., Ossei-Gerning N., Grant P. J. Platet Glycoprotein IIIa P1A Polymorphism in Young Man with Myocardial Infarction. Lancet. 1996; 348: 485–486
- Carter A. M., Catto A. J., Bamford J. M., Grant P. J. Platelet GpIIIa P1A and Gp Ib Variable Number Tandem Repeat Polymorphisms and Markers of Platelet Activation in Acute Stroke. Arterioscler. Thromb. Vasc. Biol. 1998; 18(7)1124–1131
- Wagner K. R., Giles W. H., Johnson C. J., Ou C. Y., Bray P. F., Goldschmidt-Clermont P. J., Croft J. B., Brown V. K., Stern B. J., Feeser B. R., Buchholz D. W., Earley C. J., Macko R. F., McCarter R. J., Sloan M. A., Stolley P. D., Wityk R. J., Wozniak M. A., Price T. R., Kittner S. J. Platelet Glycoprotein Receptor IIIa Polymorphism P1A2 and Ischemic Stroke Risk, The Stroke Prevention in Young Women Study. Stroke. 1998; 29(3)581–585
- Cambien F., Poirier O., Lecerf L., Evans A., Cambou J. P., Arveiler D., Luc G., Bard J. M., Bara L., Ricard S. Deletion Polymorphism in the Gene for Angiotensin-Converting Enzyme is a Potent Risk Factor for Myocardial Infarction. Nature. 1992; 359(6396)641–644
- Sharma P. Meta-Analysis of the ACE Gene in Ischaemic stroke. J. Neurol. Neurosurg. Psychiatry. 1998; 64(2)227–230
- MacLeod M. J., Dahiyat M. T., Cumming A., Meiklejohn D., Shaw D., St Clair D. No Association Between Glu/Asp Polymorphism of NOS3 Gene and Ischemic Stroke. Neurology. 1999; 53(2)418–420
- Brattstrom L., Wilcken D. E., Ohrvik J., Brudin L. Common Methylenetetrahydrofolate Reductase Gene Mutation Leads to Hyperhomocysteinemia But Not to Vascular Disease, the Result of a Meta-Analysis. Circulation. 1998; 98(23)2520–2526
- McCarron M. O., Delong D., Alberts M. J. APOE Genotype as a Risk Factor for Ischemic Cerebrovascular Disease, a Meta-Analysis. Neurology. 1999; 53(6)1308–1311
- Benlian P., Aalto-Setala K., Dieplinger H., Hofker M., James R., Poledne R., Talmud P., Vilaro S. (1999) European Lipoprotein Club, Report of the 21st Annual Conference, Tutzing. Atherosclerosis., September28–October 1,, 1999. Atherosclerosis., 449–458
- Huang P., Kostulas K., Huang W. X., Crisby M., Kostulas V., Hillert J. Lipoprotein Lipase Gene Polymorphisms in Ischaemic Stroke and Carotid Stenosis. Eur. J. Clin. Invest. 1997; 27(9)740–742